🇺🇸 FDA
Patent

US 10751348

Formulations of testosterone and methods of treatment therewith

granted A61KA61K31/568A61K31/5685

Quick answer

US patent 10751348 (Formulations of testosterone and methods of treatment therewith) held by The Board of Regents of the University of Texas System expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/568, A61K31/5685, A61K31/573, A61K45/06